International Journal of Immunopharmacology 1989-01-01

Studies on the immunosuppressive properties of 7,25 dihydroxycholesterol--II. Effects on early steps of T-cell activation.

C Moog, B Luu, A Altmeyer, P Bischoff

Index: Int. J. Immunopharmacol. 11(5) , 559-65, (1989)

Full Text: HTML

Abstract

The effects of an oxysterol, 7,25-dihydroxycholesterol (7,25-OHC), cyclosporin A (CsA) and dexamethasone (Dex) on the blastogenic response of murine lymphocytes to various stimuli were investigated. 7,25-OHC markedly depressed the response to Con A, anti-T3 monoclonal antibodies and to the combination phorbol myristate acetate (PMA) + IL-2 and PMA + ionomycin. Dexamethasone was also active within the same range of concentrations. However, it did not inhibit the stimulation induced by PMA + ionomycin. On the other hand, Cs A failed to depress the lymphocyte response to IL-2 + PMA. Therefore, the mechanisms of action involved in the blockage of lymphocyte activation are different for these three compounds. Moreover, we noted that 7,25-OHC was less active upon purified T-cells. Taken together, these results suggest that 7,25-OHC may act at the level of signal transduction across the membrane.


Related Compounds

Related Articles:

Detection of dihydroxycholesterols in human plasma using HPLC-ESI-MS/MS.

2015-07-01

[Steroids 99 , 131-8, (2015)]

Studies on the relationships between 7 alpha-hydroxylation and the ability of 25- and 27-hydroxycholesterol to suppress the activity of HMG-CoA reductase.

1997-02-18

[Biochim. Biophys. Acta 1344(3) , 241-9, (1997)]

Molecular characterization of oxysterol binding to the Epstein-Barr virus-induced gene 2 (GPR183).

2012-10-12

[J. Biol. Chem. 287(42) , 35470-83, (2012)]

Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses.

2012-09-21

[Immunity 37(3) , 535-48, (2012)]

Studies on the immunosuppressive properties of 7,25-dihydroxycholesterol--I. Reduction of interleukin production by treated lymphocytes.

1988-01-01

[Int. J. Immunopharmacol. 10(5) , 511-8, (1988)]

More Articles...